127 results on '"Marino, N."'
Search Results
2. Pluronic® P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
- Author
-
Pellosi DS, Moret F, Fraix A, Marino N, Maiolino S, Gaio E, Hioka N, Reddi E, Sortino S, and Quaglia F
- Subjects
Pluronic Micelles ,Sorafenib ,Chemotherapy ,Photodynamic Therapy ,Verteporfin ,Medicine (General) ,R5-920 - Abstract
Diogo Silva Pellosi,1,2,* Francesca Moret,3,* Aurore Fraix,4 Nino Marino,4 Sara Maiolino,2 Elisa Gaio,3 Noboru Hioka,1 Elena Reddi,3 Salvatore Sortino,4 Fabiana Quaglia2 1Research Nucleus of Photodynamic Therapy, Chemistry Department, State University of Maringá, Maringá, Brazil; 2Drug Delivery Laboratory, Department of Pharmacy, University of Naples Federico II, Naples, 3Cell Biology Unit, Department of Biology, University of Padova, Padua, 4Laboratory of Photochemistry, Department of Drug Sciences, University of Catania, Catania, Italy *These authors contributed equally to this work Abstract: Here, we developed Pluronic® P123/F127 (poloxamer) mixed micelles for the intravenous delivery of the anticancer drug sorafenib (SRB) or its combination with verteporfin (VP), a photosensitizer for photodynamic therapy that should complement well the cytotoxicity profile of the chemotherapeutic. SRB loading inside the core of micelles was governed by the drug:poloxamer weight ratio, while in the case of the SRB–VP combination, a mutual interference between the two drugs occurred and only specific ratios could ensure maximum loading efficiency. Coentrapment of SRB did not alter the photophysical properties of VP, confirming that SRB did not participate in any bimolecular process with the photosensitizer. Fluorescence resonance energy-transfer measurement of micelles in serum protein-containing cell-culture medium demonstrated the excellent stability of the system in physiologically relevant conditions. These results were in line with the results of the release study showing a release rate of both drugs in the presence of proteins slower than in phosphate buffer. SRB release was sustained, while VP remained substantially entrapped in the micelle core. Cytotoxicity studies in MDA-MB231 cells revealed that at 24 hours, SRB-loaded micelles were more active than free SRB only at very low SRB concentrations, while at 24+24 hours a prolonged cytotoxic effect of SRB-loaded micelles was observed, very likely mediated by the block in the S phase of the cell cycle. The combination of SRB with VP under light exposure was less cytotoxic than both the free combination and VP-loaded micelles + SRB-loaded micelles combination. This behavior was clearly explainable in terms of micelle uptake and intracellular localization. Besides the clear advantage of delivering SRB in poloxamer micelles, our results provide a clear example that each photochemotherapeutic combination needs detailed investigations on their particular interaction, and no generalization on enhanced cytotoxic effects should be derived a priori. Keywords: Pluronic® micelles, sorafenib, chemotherapy, photodynamic therapy, verteporfin
- Published
- 2016
3. Digital biomarkers and sex impacts in Alzheimer's disease management - potential utility for innovative 3P medicine approach
- Author
-
Harms, RL, Ferrari, A, Meier, IB, Martinkova, J, Santus, E, Marino, N, Cirillo, D, Mellino, S, Solarz, SC, Tarnanas, I, Szoeke, C, Hort, J, Valencia, A, Ferretti, MT, Seixas, A, Chadha, AS, Harms, RL, Ferrari, A, Meier, IB, Martinkova, J, Santus, E, Marino, N, Cirillo, D, Mellino, S, Solarz, SC, Tarnanas, I, Szoeke, C, Hort, J, Valencia, A, Ferretti, MT, Seixas, A, and Chadha, AS
- Abstract
UNLABELLED: Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices. Their use has revolutionized clinical research by enabling high-frequency, longitudinal, and sensitive measurements. In the field of neurodegenerative diseases, an example of a digital biomarker-based technology is instrumental activities of daily living (iADL) digital medical application, a predictive biomarker of conversion from mild cognitive impairment (MCI) due to Alzheimer's disease (AD) to dementia due to AD in individuals aged 55 + . Digital biomarkers show promise to transform clinical practice. Nevertheless, their use may be affected by variables such as demographics, genetics, and phenotype. Among these factors, sex is particularly important in Alzheimer's, where men and women present with different symptoms and progression patterns that impact diagnosis. In this study, we explore sex differences in Altoida's digital medical application in a sample of 568 subjects consisting of a clinical dataset (MCI and dementia due to AD) and a healthy population. We found that a biological sex-classifier, built on digital biomarker features captured using Altoida's application, achieved a 75% ROC-AUC (receiver operating characteristic - area under curve) performance in predicting biological sex in healthy individuals, indicating significant differences in neurocognitive performance signatures between males and females. The performance dropped when we applied this classifier to more advanced stages on the AD continuum, including MCI and dementia, suggesting that sex differences might be disease-stage dependent. Our results indicate that neurocognitive performance signatures built on data from digital biomarker features are different between men and women. These results stress the need to integrate traditional approaches to dementia research with digital biomarker technologies and personalized medicine persp
- Published
- 2022
4. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
- Author
-
Portale, F, Cricrì, G, Bresolin, S, Lupi, M, Gaspari, S, Silvestri, D, Russo, B, Marino, N, Ubezio, P, Pagni, F, Vergani, P, Te Kronnie, G, Valsecchi, M, Locatelli, F, Rizzari, C, Biondi, A, Dander, E, D'Amico, G, Portale F, Cricrì G, Bresolin S, Lupi M, Gaspari S, Silvestri D, Russo B, Marino N, Ubezio P, Pagni F, Vergani P, Te Kronnie G, Valsecchi MG, Locatelli F, Rizzari C, Biondi A, Dander E, D'Amico G., Portale, F, Cricrì, G, Bresolin, S, Lupi, M, Gaspari, S, Silvestri, D, Russo, B, Marino, N, Ubezio, P, Pagni, F, Vergani, P, Te Kronnie, G, Valsecchi, M, Locatelli, F, Rizzari, C, Biondi, A, Dander, E, D'Amico, G, Portale F, Cricrì G, Bresolin S, Lupi M, Gaspari S, Silvestri D, Russo B, Marino N, Ubezio P, Pagni F, Vergani P, Te Kronnie G, Valsecchi MG, Locatelli F, Rizzari C, Biondi A, Dander E, and D'Amico G.
- Abstract
B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-b family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34 + cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche.
- Published
- 2019
5. Training Simulators for Gastrointestinal Endoscopy: Current and Future Perspectives
- Author
-
Finocchiaro M, Cortegoso Valdivia P, Hernansanz A, Marino N, Amram D, Casals-Gelpi A, Menciassi A, Marlicz W, Ciuti G, and Koulaouzidis A
- Subjects
gastroscopy ,training ,colonoscopy ,simulators ,GI endoscopy ,medical simulation ,medical education - Abstract
Gastrointestinal (GI) endoscopy is the gold standard in the detection and treatment of early and advanced GI cancers. However, conventional endoscopic techniques are technically demanding and require visual-spatial skills and significant hands-on experience. GI endoscopy simulators represent a valid solution to allow doctors to practice in a pre-clinical scenario. From the first endoscopy mannequin, developed in 1969, several simulation platforms have been developed, ranging from purely mechanical systems to more complex mechatronic devices and animal-based models. Considering the recent advancement of technologies (e.g., artificial intelligence, augmented reality, robotics), simulation platforms can now reach high levels of realism, representing a valid and smart alternative to standard trainee/mentor learning programs. This is particularly true nowadays, when the current demographic trend and the most recent pandemic demand, more than ever, the ability to cope with many patients. This review offers a broad view of the technology available for GI endoscopy training, including platforms currently in the market and the relevant advancements in this research and application field. Additionally, new training needs and new emerging technologies are discussed to understand where medical education is heading.
- Published
- 2021
6. Publisher Correction: Hierarchical organization of perylene bisimides and polyoxometalates for photo-assisted water oxidation (Nature Chemistry, (2019), 11, 2, (146-153), 10.1038/s41557-018-0172-y)
- Author
-
Bonchio, M., Syrgiannis, Z., Burian, M., Marino, N., Pizzolato, E., Dirian, K., Rigodanza, F., Volpato, G. A., La Ganga, G., Demitri, N., Berardi, S., Amenitsch, H., Guldi, D. M., Caramori, S., Bignozzi, C. A., Sartorel, A., Prato, M., Bonchio, M., Syrgiannis, Z., Burian, M., Marino, N., Pizzolato, E., Dirian, K., Rigodanza, F., Volpato, G. A., La Ganga, G., Demitri, N., Berardi, S., Amenitsch, H., Guldi, D. M., Caramori, S., Bignozzi, C. A., Sartorel, A., and Prato, M.
- Subjects
water oxidation ,polyoxometalate ,perylene bisimides ,perylene bisimides, polyoxometalate, water oxidation - Abstract
The oxygen in Earth’s atmosphere is there primarily because of water oxidation performed by photosynthetic organisms using solar light and one specialized protein complex, photosystem II (PSII). High-resolution imaging of the PSII ‘core’ complex shows the ideal co-localization of multi-chromophore light-harvesting antennas with the functional reaction centre. Man-made systems are still far from replicating the complexity of PSII, as the majority of PSII mimetics have been limited to photocatalytic dyads based on a 1:1 ratio of a light absorber, generally a Ru–polypyridine complex, with a water oxidation catalyst. Here we report the self-assembly of multi-perylene-bisimide chromophores (PBI) shaped to function by interaction with a polyoxometalate water-oxidation catalyst (Ru4POM). The resulting [PBI]5Ru4POM complex shows a robust amphiphilic structure and dynamic aggregation into large two-dimensional paracrystalline domains, a redshifted light-harvesting efficiency of >40% and favourable exciton accumulation, with a peak quantum efficiency using ‘green’ photons (λ > 500 nm). The modularity of the building blocks and the simplicity of the non-covalent chemistry offer opportunities for innovation in artificial photosynthesis.
- Published
- 2019
7. AB0716 FIBROMYALGIA SYNDROME SEVERITY ACCORDING TO AGE CATEGORIES: RESULTS FROM A NATIONAL REGISTER
- Author
-
Di Carlo, M., primary, Farah, S., additional, Bazzichi, L., additional, Atzeni, F., additional, Govoni, M., additional, Biasi, G., additional, DI Franco, M., additional, Mozzani, F., additional, Gremese, E., additional, Dagna, L., additional, Batticciotto, A., additional, Fischetti, F., additional, Giacomelli, R., additional, Guiducci, S., additional, Guggino, G., additional, Bentivegna, M., additional, Gerli, R., additional, Salvarani, C., additional, Bajocchi, G., additional, Ghini, M., additional, Iannone, F., additional, Giorgi, V., additional, Cirillo, M., additional, Bonazza, S., additional, Barbagli, S., additional, Gioia, C., additional, Marino, N. G., additional, Capacci, A., additional, Cavalli, G., additional, Cappelli, A., additional, Carubbi, F., additional, Nacci, F., additional, Ilenia, R., additional, Cutolo, M., additional, Sinigaglia, L., additional, Sarzi-Puttini, P., additional, and Salaffi, F., additional
- Published
- 2021
- Full Text
- View/download PDF
8. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015
- Author
-
Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Quiros-Roldan E., Magro P., Raffetti E., Izzo I., Borghetti A., Lombardi F., Saracino A., Maggiolo F., Castelli F., Carosi G., Paraninfo G. E., Torti C., Cauda R., Di Giambenedetto S., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Di Pietro M., Ble C., Vichi F., Sighinolfi L., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Lapadula G., Puoti M., Viale P., Colangeli V., Borderi M., Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Quiros-Roldan E., Magro P., Raffetti E., Izzo I., Borghetti A., Lombardi F., Saracino A., Maggiolo F., Castelli F., Carosi G., Paraninfo G. E., Torti C., Cauda R., Di Giambenedetto S., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Di Pietro M., Ble C., Vichi F., Sighinolfi L., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Lapadula G., Puoti M., Viale P., Colangeli V., and Borderi M.
- Abstract
Background: Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical and inflammatory indices in patients switching to dual therapy (DT). Methods: We included patients that a) switched to a DT from 2007 to 2015 from a tenofovir/abacavir-based triple regimen b) previously maintained a triple and c) subsequently a dual regimen for 12 months with virological suppression. We retrieved data measured at 5 points (at the switch, 6 and 12 months before and after switch). We used platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and CD4/CD8 ratio as inflammatory indices. We assessed temporal trends of viro-immunological, biochemical and inflammatory parameters. Results: Overall, 364 and 65 patients switched from a tenofovir- and an abacavir-triple regimen, respectively. In the tenofovir-reducing group, creatinine clearance and lipids raised after the switch. There was a significant increase in both CD4+ cells and CD4/CD8. CD8+ cells rose after the switch, while opposite trend was found for PLR. In the abacavir-reducing group total lipids showed a decrease during the first 6 months after the switch and then stabilized. An increase of CD4+ and a decrease of CD8+ cells was observed during the study period, although not statistically significant. While CD4/CD8 remained stable after simplification, PLR decreased significantly after 6 months, then returning to baseline. CD8+ cells increased in the tenofovir-reducing group despite a viro-immunological response. Intriguingly, PLR decreased, maintaining this trend for 12 and 6 months after tenofovir and abacavir interruption respectively. Conclusions: Increased PLR has been linked to hypercholesterolemia and metabolic-syndrome, while high CD8+ cells count to increased risk of non-AIDS-related events regardless of CD4 T-cell re
- Published
- 2018
9. In situ resistance, not immigration, supports invertebrate community resilience to drought intensification in a Neotropical ecosystem
- Author
-
Bonhomme, C., Cereghino, R., Carrias, J. F., Compin, A., Corbara, B., Jassey, V. E. J., Leflaive, J., Farjalla, V. F., Marino, N. A. C., Rota, T., Srivastava, D. S., and Leroy, Céline
- Subjects
resistance ,functional ,climate change ,traits ,freshwater ecosystems ,fungi ,food and beverages ,community ,drought ,invertebrates ,resilience - Abstract
While future climate scenarios predict declines in precipitations in many regions of the world, little is known of the mechanisms underlying community resilience to prolonged dry seasons, especially in 'naive' Neotropical rainforests. Predictions of community resilience to intensifying drought are complicated by the fact that the underlying mechanisms are mediated by species' tolerance and resistance traits, as well as rescue through dispersal from source patches. We examined the contribution of in situ tolerance-resistance and immigration to community resilience, following drought events that ranged from the ambient norm to IPCC scenarios and extreme events. We used rainshelters above rainwater-filled bromeliads of French Guiana to emulate a gradient of drought intensity (from 1 to 3.6 times the current number of consecutive days without rainfall), and we analysed the post-drought dynamics of the taxonomic and functional community structure of aquatic invertebrates to these treatments when immigration is excluded (by netting bromeliads) or permitted (no nets). Drought intensity negatively affected invertebrate community resistance, but had a positive influence on community recovery during the post-drought phase. After droughts of 1 to 1.4 times the current intensities, the overall invertebrate abundance recovered within invertebrate life cycle durations (up to 2 months). Shifts in taxonomic composition were more important after longer droughts, but overall, community composition showed recovery towards baseline states. The non-random patterns of changes in functional community structure indicated that deterministic processes like environmental filtering of traits drive community re-assembly patterns after a drought event. Community resilience mostly relied on in situ tolerance-resistance traits. A rescue effect of immigration after a drought event was weak and mostly apparent under extreme droughts. Under climate change scenarios of drought intensification in Neotropical regions, community and ecosystem resilience could primarily depend on the persistence of suitable habitats and on the resistance traits of species, while metacommunity dynamics could make a minor contribution to ecosystem recovery. Climate change adaptation should thus aim at identifying and preserving local conditions that foster in situ resistance and the buffering effects of habitat features.
- Published
- 2020
10. Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015
- Author
-
Quiros-Roldan, E., Magro, P., Raffetti, E., Izzo, I., Borghetti, Alberto, Lombardi, Francesca, Saracino, A., Maggiolo, F., Castelli, F., Carosi, Giulia, Paraninfo, G. E., Torti, Carlo, Cauda, Roberto, Di Giambenedetto, Simona, Fabbiani, M., Colafigli, Manuela, Scalzini, A., Castelnuovo, F., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Di Pietro, Maria Luisa, Ble, C., Vichi, F., Sighinolfi, L., Angarano, G., Ladisa, N., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Quiros-Roldan, E, Magro, P, Raffetti, E, Izzo, I, Borghetti, A, Lombardi, F, Saracino, A, Maggiolo, F, Castelli, F, Carosi, G, Paraninfo, G, Torti, C, Cauda, R, Di Giambenedetto, S, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Di Pietro, M, Ble, C, Vichi, F, Sighinolfi, L, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Lapadula, G, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Blè, C, and Border, M
- Subjects
0301 basic medicine ,Male ,HIV Infections ,Gastroenterology ,Cohort Studies ,0302 clinical medicine ,Abacavir ,Antiretroviral Therapy, Highly Active ,030212 general & internal medicine ,Darunavir ,virus diseases ,Switch ,Middle Aged ,Antiretroviral therapy ,Infectious Diseases ,Treatment Outcome ,Italy ,Reverse Transcriptase Inhibitors ,Female ,medicine.symptom ,medicine.drug ,Research Article ,Adult ,medicine.medical_specialty ,Anti-HIV Agents ,Dual-therapy ,HIV ,Inflammation ,Atazanavir Sulfate ,CD4-CD8 Ratio ,Renal function ,Settore MED/17 - MALATTIE INFETTIVE ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,Immune system ,Internal medicine ,medicine ,Humans ,lcsh:RC109-216 ,Tenofovir ,Retrospective Studies ,business.industry ,Retrospective cohort study ,Reverse transcriptase ,Dideoxynucleosides ,Regimen ,030104 developmental biology ,business ,CD8 - Abstract
Background Triple-drug regimens are the gold standard for HIV therapy. Nucleos(t)ide reverse transcriptase inhibitors (NRTIs) reducing regimens are used to decrease drugs toxicity, exposure and costs. Aim of our study was to evaluate trends of biochemical and inflammatory indices in patients switching to dual therapy (DT). Methods We included patients that a) switched to a DT from 2007 to 2015 from a tenofovir/abacavir-based triple regimen b) previously maintained a triple and c) subsequently a dual regimen for 12 months with virological suppression. We retrieved data measured at 5 points (at the switch, 6 and 12 months before and after switch). We used platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR) and CD4/CD8 ratio as inflammatory indices. We assessed temporal trends of viro-immunological, biochemical and inflammatory parameters. Results Overall, 364 and 65 patients switched from a tenofovir- and an abacavir-triple regimen, respectively. In the tenofovir-reducing group, creatinine clearance and lipids raised after the switch. There was a significant increase in both CD4+ cells and CD4/CD8. CD8+ cells rose after the switch, while opposite trend was found for PLR. In the abacavir-reducing group total lipids showed a decrease during the first 6 months after the switch and then stabilized. An increase of CD4+ and a decrease of CD8+ cells was observed during the study period, although not statistically significant. While CD4/CD8 remained stable after simplification, PLR decreased significantly after 6 months, then returning to baseline. CD8+ cells increased in the tenofovir-reducing group despite a viro-immunological response. Intriguingly, PLR decreased, maintaining this trend for 12 and 6 months after tenofovir and abacavir interruption respectively. Conclusions Increased PLR has been linked to hypercholesterolemia and metabolic-syndrome, while high CD8+ cells count to increased risk of non-AIDS-related events regardless of CD4 T-cell recovery and to virological failure. Whether these findings may have clinical implications, and which role DT plays on the immune system and on inflammation should be further investigated.
- Published
- 2018
11. Use of PET/CT to detect local and regional laryngeal cancer recurrence after surgery
- Author
-
Allegra E, Saita V, De Natale M, Marino N, Trapasso S, Tamburrini S, Alessio C, and Ippolito M
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,PET/CT imaging ,lcsh:R895-920 ,laryngeal cancer ,local and regional laryngeal cancer recurrence - Abstract
Eugenia Allegra,1 Vincenzo Saita,2 Massimo De Natale,2 Nicolò Marino,2 Serena Trapasso,1 Stefania Tamburrini,3 Caterina Alessio,4 Massimo Ippolito5 1Otolaryngology, Department of Health Sciences, University of Catanzaro, Catanzaro, 2Department of Otolaryngology, Cannizzaro Hospital, Catania, 3Department of Radiology, Pellegrini Hospital, Naples, 4Department of Experimental and Clinical Medicine-Radiology, University of Catanzaro, Catanzaro, 5Department of Nuclear Medicine, Cannizzaro Hospital, Catania, Italy Background: Laryngeal cancer is the second most common cancer of the head and neck after cancer of the oral cavity. The primary causes of death in cases of laryngeal cancer are the recurrence of locoregional disease and distant metastasis. Anatomic and tissue alterations resulting from surgery and/or radiotherapy of primary laryngeal tumors can make it difficult to determine a locoregional recurrence or residual disease by physical examination or computed tomography (CT)/magnetic resonance imaging (MRI). The majority of studies have shown a high accuracy in the detection of local and regional recurrence of head and neck cancer after different treatment modalities, using fluorodeoxyglucose (FDG)-positron emission tomography (PET)/CT.Aim: To determine the diagnostic accuracy of PET/CT in patients with suspicion of locoregional recurrence from laryngeal carcinoma after surgery with or without adjuvant radiotherapy.Materials and methods: This was a retrospective study. Forty-five patients who previously underwent surgical treatment with or without adjuvant radiotherapy for primary laryngeal squamous cell carcinoma and who underwent examination using FDG-PET/CT imaging after clinical and instrumental (CT/MRI) suspicion of locoregional recurrence (T or N) were recruited.Results: Overall specificity, sensitivity, and accuracy of PET/CT were found to be 88%, 100%, and 93.3%, respectively. With respect to the suspected cases of recurrence in the primary site, sensitivity, specificity, and accuracy of PET/CT were found to be 100%, 87.5%, and 91.6%, respectively. In patients with suspected metastatic neck disease, PET/CT revealed a sensitivity, specificity, and accuracy of 100%, 90%, and 95.4%, respectively.Conclusion: According to the results of this study, PET/CT imaging in laryngeal tumors is a useful tool in case of suspected locoregional recurrence where conventional imaging (CT and MRI) is unable to resolve the diagnostic doubt. Keywords:laryngealcancer, PET/CT imaging, laryngeal cancer recurrence, laryngeal cancer PET/CT imaging
- Published
- 2017
12. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
- Author
-
Portale, F., Cricri, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, Franco, Rizzari, C., Biondi, A., Dander, E., D'Amico, G., Locatelli F. (ORCID:0000-0002-7976-3654), Portale, F., Cricri, G., Bresolin, S., Lupi, M., Gaspari, S., Silvestri, D., Russo, B., Marino, N., Ubezio, P., Pagni, F., Vergani, P., Te Kronnie, G., Valsecchi, M. G., Locatelli, Franco, Rizzari, C., Biondi, A., Dander, E., D'Amico, G., and Locatelli F. (ORCID:0000-0002-7976-3654)
- Abstract
B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-b family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34 + cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche.
- Published
- 2019
13. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function
- Author
-
Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Postorino M. C., Quiros-Roldan E., Maggiolo F., di Giambenedetto S., Ladisa N., Lapadula G., Lorenzotti S., Sighinolfi L., Castelnuovo F., di Pietro M., Gotti D., Mazzini N., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Fabbiani M., Colafigli M., Scalzini A., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Puoti M., Viale P., Colangeli V., Borderi M., Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Postorino M. C., Quiros-Roldan E., Maggiolo F., di Giambenedetto S., Ladisa N., Lapadula G., Lorenzotti S., Sighinolfi L., Castelnuovo F., di Pietro M., Gotti D., Mazzini N., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Fabbiani M., Colafigli M., Scalzini A., El Hamad I., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Monno L., Maggi P., Pan A., Costarelli S., Gori A., Puoti M., Viale P., Colangeli V., and Borderi M.
- Abstract
Background and Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by ritonavir, ATV/r) could perpetuate some degrees of renal impairment with or without TDF co-administration. Also, possible benefits of stopping TDF in patients without renal diseases is not well known. This study aimed at exploring evolution of renal function and lipid profile after switching from tenofovir/emtricitabine (TDF/FTC) to abacavir/lamivudine (ABC/3TC), maintaining the ATV/r component of the regimen. Methods: Patients in the Italian MASTER Cohort, who switched from TDF/FTC plus ATV/r to ABC/3TC plus ATV/r were included, provided that major renal diseases were not diagnosed before switching (i.e., baseline). Serum creatinine, estimated glomerular filtration rate (eGFR), total cholesterol, HDL and triglycerides were evaluated at baseline and at month 18 after switching. Results: 126 patients were selected (80% males). Patients were mostly Italians (92%). 79% had undetectable HIV-RNA and 44% were coinfected by HBV and/or HCV. Median age at switch was 47 years (IQR 43-55). A small but significant decrease in serum creatinine [from 1.06 mg/dl (SD: 0.3) to 0.94 mg/dl (SD: 0.2); p<0.001] with an improvement in eGFR [from 86.8 ml/min (SD: 33) to 96.4 ml/min (SD: 37); p<0.001] were observed in per protocol analysis at month 18. Also ITT analysis showed a decrease in mean serum creatinine [from 1.08 mg/dl (SD: 0.35) to 0.95 mg/dl (SD: 0.24); p<0.001] with an improvement in mean eGFR [from 86.9 ml/min/1.73m2 (SD: 24.11) to 95.8 ml/min/1.73m2 (SD: 19.99); p<0.001]. Total cholesterol increased [from 188 mg/dl (SD: 42) to 206 mg/dl (SD: 44); p<0.001] but also HDL increased as well [from 46 mg/dl (SD: 14) to 54 mg/dl (SD: 19); p=0.015]. An increase in triglycerides concentration was observed [from 162 mg/dl (SD: 144) to 214 mg/dl (SD: 109); p=0.0
- Published
- 2016
14. Risk of Severe Non AIDS Events Is Increased among Patients Unable to Increase their CD4+ T-Cell Counts >200+/μl Despite Effective HAART
- Author
-
LAPADULA, GIUSEPPE, GORI, ANDREA, Chatenoud, L, Castelli, F, Di Giambenedetto, S, Fabbiani, M, Maggiolo, F, Focà, E, Ladisa, N, Sighinolfi, L, Di Pietro, M, Pan, A, Torti, C, Carosi, G, Quiros, E, Nasta, P, Paraninfo, G, Cauda, R, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Pierotti, P, Marino, N, Blè, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Costarelli, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M., Lapadula, G, Chatenoud, L, Gori, A, Castelli, F, Di Giambenedetto, S, Fabbiani, M, Maggiolo, F, Focà, E, Ladisa, N, Sighinolfi, L, Di Pietro, M, Pan, A, Torti, C, Carosi, G, Quiros, E, Nasta, P, Paraninfo, G, Cauda, R, Colafigli, M, Scalzini, A, Castelnuovo, F, El Hamad, I, Mazzotta, F, Locaputo, S, Pierotti, P, Marino, N, Blè, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Costarelli, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Lapadula, G., Chatenoud, L., Gori, A., Castelli, F., Di Giambenedetto, S., Fabbiani, M., Maggiolo, F., Foca, E., Ladisa, N., Sighinolfi, L., Di Pietro, M., Pan, A., Torti, C., Carosi, G., Quiros, E., Nasta, P., Paraninfo, G., Cauda, R., Colafigli, M., Scalzini, A., Castelnuovo, F., El Hamad, I., Mazzotta, F., Locaputo, S., Pierotti, P., Marino, N., Ble, C., Vichi, F., Angarano, G., Monno, L., Maggi, P., Costarelli, S., Puoti, M., Viale, P., Colangeli, V., and Borderi, M.
- Subjects
Male ,Comorbidity ,medicine.disease_cause ,Risk Factors ,Neoplasms ,Antiretroviral Therapy, Highly Active ,Cardiovascular Disease ,education.field_of_study ,Multidisciplinary ,Coinfection ,Incidence (epidemiology) ,Liver Diseases ,Liver Disease ,Medicine (all) ,Hepatitis C ,Middle Aged ,Viral Load ,Cardiovascular Diseases ,Disease Progression ,Medicine ,Female ,Viral load ,Research Article ,Human ,Adult ,medicine.medical_specialty ,Science ,Hepatitis C virus ,Population ,Antiretroviral Therapy ,Settore MED/17 - MALATTIE INFETTIVE ,Acquired immunodeficiency syndrome (AIDS) ,Internal medicine ,medicine ,Humans ,Highly Active ,education ,Acquired Immunodeficiency Syndrome ,Biochemistry, Genetics and Molecular Biology (all) ,business.industry ,Risk Factor ,medicine.disease ,CD4 Lymphocyte Count ,cd4 ,Agricultural and Biological Sciences (all) ,Immunology ,Neoplasm ,business - Abstract
Background: Immunological non-response (INR) despite virological suppression is associated with AIDS-defining events/death (ADE). Little is known about its association with serious non-AIDS-defining events (nADE). Methods Patients highly-active antiretroviral therapy (HAART) with 50. Results: 1221 patients were observed for a median of 3 (IQR: 1.3-6.1) years. Pre-HAART CD4+were 77/μl (IQR: 28-142) and 56% of patients had experienced an ADE. After 1 year, CD4+ increased to 286 (IQR: 197-387), but 26.1% of patients were INR. Thereafter, 86 nADE (30.2% malignancies, 27.9%infectious, 17.4%renal, 17.4Êrdiovascular, 7% hepatic) were observed, accounting for an incidence of 1.83 events (95%CI: 1.73-2.61) per 100 PYFU. After adjusting for measurable confounders, INR had a significantly greater risk of nADE (HR 1.65; 95%CI: 1.06-2.56). Older age (per year, HR 1.03; 95%CI: 1.01-1.05), hepatitis C co-infection (HR 2.09; 95%CI: 1.19-3.7), a history of previous nADE (HR 2.16; 95% CI: 1.06-4.4) and the occurrence of ADE during the follow-up (HR 2.2; 95%CI: 1.15-4.21) were other independent predictors of newly diagnosed nADE. Conclusions: Patients failing to restore CD4+ to >200 cells/μl run a greater risk of serious nADE, which is intertwined or predicted by AIDS progression. Improved management of this fragile population and innovative therapy able to induce immune-reconstitution are urgently needed. Also, our results strengthen the importance of earlier diagnosis and HAART introduction.
- Published
- 2015
15. Functional traits and environmental conditions predict community isotopic niches and energy pathways across spatial scales
- Author
-
Dézerald, O., Srivastava, D. S., Céréghino, R., Carrias, J. F., Corbara, B., Farjalla, V. F., Leroy, Céline, Marino, N. A. C., Piccoli, G. C. O., Richardson, B. A., Richardson, M. J., Romero, G. Q., and Gonzalez, A. L.
- Subjects
functional biogeography ,metacommunity ,food webs ,trophic structure ,environmental heterogeneity ,functional diversity ,isotopic niche ,energy pathways - Abstract
1. Despite ongoing research in food web ecology and functional biogeography, the links between food web structure, functional traits and environmental conditions across spatial scales remain poorly understood. Trophic niches, defined as the amount of energy and elemental space occupied by species and food webs, may help bridge this divide. 2. Here, we ask how the functional traits of species, the environmental conditions of habitats and the spatial scale of analysis jointly determine the characteristics of trophic niches. We used isotopic niches as a proxy of trophic niches, and conducted analyses at spatial scales ranging from local food webs and metacommunities to geographically distant sites. 3. We sampled aquatic macroinvertebrates from 104 tank bromeliads distributed across five sites from Central to South America and compiled the macroinvertebrates' functional traits and stable isotope values (delta N-15 and delta C-13). We assessed how isotopic niches within each bromeliad were influenced by the functional trait composition of their associated invertebrates and environmental conditions (i.e., habitat size, canopy cover [CC] and detrital concentration [DC]). We then evaluated whether the diet of dominant predators and, consequently, energy pathways within food webs reflected functional and environmental changes among bromeliads across sites. At last, we determined the extent to which the isotopic niches of macroinvertebrates within each bromeliad contributed to the metacommunity isotopic niches within each site and compared these metacommunity-level niches over biogeographic scales. 4. At the bromeliad level, isotopic niches increased with the functional richness of species in the food web and the DC in the bromeliad. The diet of top predators tracked shifts in prey biomass along gradients of CC and DC. Bromeliads that grew under heterogeneous CC displayed less trophic redundancy and therefore combined to form larger metacommunity isotopic niches. At last, the size of metacommunity niches depended on within-site heterogeneity in CC. 5. Our results suggest that the trophic niches occupied by food webs can predictably scale from local food webs to metacommunities to biogeographic regions. This scaling process is determined by both the functional traits of species and heterogeneity in environmental conditions.
- Published
- 2018
16. Confined photo-release of nitric oxide with simultaneous two-photon fluorescence tracking in a cellular system
- Author
-
Thomsen, H., Marino, N., Conoci, S., Sortino, S., and Ericson, M. B.
- Subjects
Photons ,Microscopy, Confocal ,Ultraviolet Rays ,Synthase, Nitric oxide, Cell line ,lcsh:R ,lcsh:Medicine ,Nitric Oxide ,Synthase ,Fluorescence ,Article ,Cell Line ,Humans ,lcsh:Q ,lcsh:Science - Abstract
Nitric oxide (NO) is a key signaling molecule in biological systems. New tools are required to therapeutically modulate NO levels with confined precision. This study explores the photoactivatable properties of an NO releasing compound (CPA), based on cupferron O-alkylated with an anthracene derivative. Upon light stimulation, CPA uncages two species: cupferron, which liberates NO, and an anthrylmethyl carbocation, which evolves into a fluorescent reporter. Proof-of-principle is demonstrated using one- and two-photon excitation (1PE and 2PE) in a cellular system (A431 cells). It was found that 1PE induces cell toxicity, while 2PE does not. Since 1PE using UV light is more likely to generate cellular photodamage, the cell toxicity observed using 1PE is most likely a combinatory effect of NO release and other UV-induced damage, which should be subject to further investigation. On the other hand, absence of phototoxicity using 2PE suggests that NO alone is not cytotoxic. This leads to the conclusion that the concept of 2PE photorelease of NO from CPA enable opportunities for biological studies of NO signaling with confined precision of NO release with minimal cytotoxicity.
- Published
- 2018
17. Exploratory analysis for the evaluation of estimated glomerular filtration rate, cholesterol and triglycerides after switching from tenofovir/emtricitabine plus atazanavir/ritonavir (ATV/r) to abacavir/lamivudine plus ATV/r in patients with preserved renal function
- Author
-
Postorino, Maria Concetta, Quiros Roldan, Eugenia, Maggiolo, Franco, Di Giambenedetto, Simona, Ladisa, Nicoletta, Lapadula, Giuseppe, Lorenzotti, Silvia, Sighinolfi, Laura, Castelnuovo, Filippo, di Pietro, Massimo, Gotti, Daria, Mazzini, Nicola, Torti, Carlo, Castelli, F., Carosi, G., Nasta, P., Paraninfo, G., Focà, E., di Giambenedetto, R. Cauda S., Fabbiani, Massimiliano, Colafigli, Manuela, Scalzini, A., El Hamad, I., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Monno, L., Maggi, P., Pan, A., Costarelli, S., Gori, A., Lapadula, G., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Postorino, M, Quiros-Roldan, E, Maggiolo, F, di Giambenedetto, S, Ladisa, N, Lapadula, G, Lorenzotti, S, Sighinolfi, L, Castelnuovo, F, di Pietro, M, Gotti, D, Mazzini, N, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Fabbiani, M, Colafigli, M, Scalzini, A, El Hamad, I, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Monno, L, Maggi, P, Pan, A, Costarelli, S, Gori, A, Puoti, M, Viale, P, Colangeli, V, and Borderi, M
- Subjects
0301 basic medicine ,Atazanavir ,Cholesterol ,eGFR ,Highly active antiretroviral therapy ,Nephrotoxicity ,Tenofovir ,Public Health, Environmental and Occupational Health ,Infectious Diseases ,Virology ,medicine.medical_specialty ,Urology ,Renal function ,Pharmacology ,Emtricitabine ,Settore MED/17 - MALATTIE INFETTIVE ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Abacavir ,medicine ,Creatinine ,business.industry ,Highly Active Antiretroviral Therapy ,Environmental and Occupational Health ,Lamivudine ,Abacavir/Lamivudine ,030112 virology ,chemistry ,Ritonavir ,Public Health ,business ,medicine.drug - Abstract
Background and Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by ritonavir, ATV/r) could perpetuate some degrees of renal impairment with or without TDF co-administration. Also, possible benefits of stopping TDF in patients without renal diseases is not well known. This study aimed at exploring evolution of renal function and lipid profile after switching from tenofovir/emtricitabine (TDF/FTC) to abacavir/lamivudine (ABC/3TC), maintaining the ATV/r component of the regimen. Methods: Patients in the Italian MASTER Cohort, who switched from TDF/FTC plus ATV/r to ABC/3TC plus ATV/r were included, provided that major renal diseases were not diagnosed before switching (i.e., baseline). Serum creatinine, estimated glomerular filtration rate (eGFR), total cholesterol, HDL and triglycerides were evaluated at baseline and at month 18 after switching. Results: 126 patients were selected (80% males). Patients were mostly Italians (92%). 79% had undetectable HIV-RNA and 44% were coinfected by HBV and/or HCV. Median age at switch was 47 years (IQR 43-55). A small but significant decrease in serum creatinine [from 1.06 mg/dl (SD: 0.3) to 0.94 mg/dl (SD: 0.2); p
- Published
- 2016
18. Flow Cytometric Measurement of the Initial In Vivo Response to Prednisone Provides New Prognostic Information in Childhood Acute Lymphoblastic Leukemia (ALL)
- Author
-
Gaipa, G, Maglia, O, Sala, S, Marino, N, Silvestri, D, Valsecchi, M, Biondi, A, Conter, V, Gaipa, Giuseppe, Maglia, Oscar, Sala, Simona, Marino, Noemi, Silvestri, Daniela, Valsecchi, Maria Grazia, Biondi, Andrea, Conter, Valentino, Gaipa, G, Maglia, O, Sala, S, Marino, N, Silvestri, D, Valsecchi, M, Biondi, A, Conter, V, Gaipa, Giuseppe, Maglia, Oscar, Sala, Simona, Marino, Noemi, Silvestri, Daniela, Valsecchi, Maria Grazia, Biondi, Andrea, and Conter, Valentino
- Abstract
Background The initial in vivo response on corticosteroid therapy (<1000 blasts/mmc at day 8 after exposure to Prednisone) is considered a prognostic predictor to qualify patients at higher risk of relapse (Riehm H et al, Klin. Padiat. 199, 1986). This parameter has been prospectively validated in several BFM-oriented trials providing evidences to be a robust predictor of disease recurrence even in specific subgroups of ALL (Schrappe M et al, Klin. Padiat. 2013). Evaluation of day8 prednisone response is assessed by morphological evaluation of peripheral blood (PB) smears, however this approach may have several limitations such as poor quality of the smears, operator- dependent variability and accuracy, poor reproducibility between centers. Methods We studied a total of 543 (of 648 eligible) patients enrolled in the AIEOP-BFM ALL 2000 study between January 2001 and December 2011 in the centers of Monza and Padova (275 and 268 patients respectively). PB collected at day+8 of induction phase was analyzed by multiparametric flow cytometry (FCM) to assess blast immunophenotyping by standard methods developed in the context of the I-BFM Flow network (Dworzak MN et al, Cytometry part B, 2008). Results Five hundred-seven patients (93.4%) had <1000 blasts/mmc as assessed by FCM, whereas 36 (6.6%) had ≥1000 blasts/mmc. Five-year Event Free Survival (5 yrs EFS) was 84.8% and 76.4% respectively (p-value =0.01). We further investigated the absolute count by sub-grouping the patients in three levels: i) 0<100 blasts/mmc (n 416), ii) ≥100<1000 blasts/mmc (n 91), and iii) ≥ 1000 blasts/mmc (n 36). 5 yrs EFS was 86.8%, 75.6% and 76.4%, respectively (p-value group a vs group b was 0.001), see Figure. Five years Cumulative Incidence of Relapse (5yrs CIR) was 11.4%, 21.1% and 17.9%, respectively (p-value group a vs group b was 0.003). When we excluded the high-risk (HR) patients from the analysis, those in the group with ≥100<1000 blasts/mmc (n71) maintained a significa
- Published
- 2018
19. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort
- Author
-
Postorino, M, Prosperi, M, Quiros-Roldan, E, Maggiolo, F, Di Giambenedetto, S, Saracino, A, Costarelli, S, Lorenzotti, S, Sighinolfi, L, Di Pietro, M, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Cauda, R, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Gori, A, Lapadula, G, Ospedale, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Policlinico, S, Postorino M. C., Prosperi M., Quiros-Roldan E., Maggiolo F., Di Giambenedetto S., Saracino A., Costarelli S., Lorenzotti S., Sighinolfi L., Di Pietro M., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Cauda R., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Gori A., Lapadula G., Ospedale S., Puoti M., Viale P., Colangeli V., Borderi M., Policlinico S., Postorino, M, Prosperi, M, Quiros-Roldan, E, Maggiolo, F, Di Giambenedetto, S, Saracino, A, Costarelli, S, Lorenzotti, S, Sighinolfi, L, Di Pietro, M, Torti, C, Castelli, F, Carosi, G, Nasta, P, Paraninfo, G, Foca, E, Cauda, R, Fabbiani, M, Colafigli, M, Scalzini, A, Castelnuovo, F, Mazzotta, F, Locaputo, S, Marino, N, Pierotti, P, Ble, C, Vichi, F, Angarano, G, Ladisa, N, Monno, L, Maggi, P, Pan, A, Gori, A, Lapadula, G, Ospedale, S, Puoti, M, Viale, P, Colangeli, V, Borderi, M, Policlinico, S, Postorino M. C., Prosperi M., Quiros-Roldan E., Maggiolo F., Di Giambenedetto S., Saracino A., Costarelli S., Lorenzotti S., Sighinolfi L., Di Pietro M., Torti C., Castelli F., Carosi G., Nasta P., Paraninfo G., Foca E., Cauda R., Fabbiani M., Colafigli M., Scalzini A., Castelnuovo F., Mazzotta F., Locaputo S., Marino N., Pierotti P., Ble C., Vichi F., Angarano G., Ladisa N., Monno L., Maggi P., Pan A., Gori A., Lapadula G., Ospedale S., Puoti M., Viale P., Colangeli V., Borderi M., and Policlinico S.
- Abstract
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy (HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunological and clinical outcomes are unclear. Patients of the Italian MASTER cohort who started HAART from 2000 to 2010 were selected. Outstanding outcome (composite outcome for success (COS)) was introduced. We evaluated predictors of COS (no AIDS plus CD4+ count >500/mm3 plus HIV-RNA <500 copies/mL) and of eight single outcomes either at month 6 or at year 3. Multivariable logistic regression was conducted. There were 6259 patients selected. Patients on EFV (43%) were younger, had greater CD4+ count, presented with AIDS less frequently, and more were Italians. At year 3, 90% of patients had HIV RNA <500 copies/mL, but only 41.4% were prescribed EFV, vs. 34.1% prescribed boosted PIs achieved COS (p <0.0001). At multivariable analysis, patients on lopinavir/ritonavir had an odds ratio of 0.70 for COS at year 3 (p <0.0001). Foreign origin and positive hepatitis C virus-Ab were independently associated with worse outcome (OR 0.54, p <0.0001 and OR 0.70, p 0.01, respectively). Patients on boosted PIs developed AIDS more frequently either at month 6 (13.8% vs. 7.6%, p <0.0001) or at year 3 (17.1% vs. 13.8%, p <0.0001). At year 3, deaths of patients starting EFV were 3%, vs. 5% on boosted PIs (p 0.008). In this study, naïve patients on EFV performed better than those on boosted PIs after adjustment for imbalances at baseline. Even when virological control is achieved, COS is relatively rare. Hepatitis C virus-positive patients and those of foreign origin are at risk of not obtaining COS.
- Published
- 2015
20. ANALISIS FINGERPRINT DAUN GEDI HIJAU (Abelmoschus manihot L) UNTUK MEMPREDIKSI AKTIVITAS ANTIOKSIDAN MENGGUNAKAN KOMBINASI SPEKTROSKOPI IR DENGAN PARTIAL LEAST SQUAREREGRESSION
- Author
-
Warongan, Marino N.
- Abstract
ANALISIS FINGERPRINT DAUN GEDI HIJAU (Abelmoschus manihot L) UNTUK MEMPREDIKSI AKTIVITAS ANTIOKSIDAN MENGGUNAKAN KOMBINASI SPEKTROSKOPI IR DENGAN PARTIALLEAST SQUAREREGRESSION Marino Novri Warongan1), Sri Sudewi1), Adithya Yudistira1)1)Program Studi Farmasi FMIPA UNSRAT Manado, 95115 ABSTRACT The study aims to determine the antioxidant activity, infrared spectra and correlation between spectral data and antioxidant activity of green gedi leaves. Method of determining prediction of antioxidant activity through fingerprint analysis using combination of IR spectroscopy and Chemometric Partial Least Square Regression (PLSR). DPPH method is used to prevent free radical and free-radical yield of free radical or concentration 150 ppm Bitung A sample 91.392 ± 1.125, Bitung B sample 88.493 ± 1.515 dan Bitung C sample 91.663 ± 1.184, Manado A sample 89.464 ± 1.642, Manado B sample 90.096 ± 3.510, and Manado C sample 89.477 ± 0.850, and in the Kotamobagu sample A 86.678 ± 3.703, Kotamobagu sample B 82.963 ± 2.991 and Kotamobagu sample C 83.163 ± 6.354. Gedi leaves from the city of Bitung, Manado, and Kotamobagu has a relatively similar spectrum. This combination involves the FTIR spectrum as the “x” variabel and the result data of the DPPH method as the “y” variabel. The prediction model can be used because it has error value ( standar error calibration (SEC = 0.0615), standard error of prediction (SEP = 0.0763)) and calibration value of 0.4181, and r validation of 0.2917. Keywords: Antioxidant, Green Gedi Leaves, FTIR Spectrophotometry, UV-VIS Spectrophotometry, Chemometric . ABSTRAK Penelitian ini bertujuan untuk mengetahui aktivitas antioksidan, spektrum infra merah dan korelasi antara data spektrum dan aktivitas antioksidan daun gedi hijau. Metode penentuan prediksi aktivitas antioksidan melaui analisis fingerprint menggunakan kombinasi Spektroskopi IR dan Kemometrik Partial Least Square Regression (PLSR). Metode DPPH digunakan untuk menangkal radikal bebas dan hasil persen penangkal radikal bebas pada konsentrasi 150 ppm Sampel Bitung A 91.392 ± 1.125, Sampel Bitung B 88.493 ± 1.515 dan Sampel Bitung C 91.663 ± 1.184, Sampel Manado A 89.464 ± 1.642, Sampel Manado B 90.096 ± 3.510, dan Sampel Manado C 89.477 ± 0.850, dan terakir pada Sampel Kotamobagu A 86.678 ± 3.703, Sampel Kotamobagu B 82.963 ± 2.991 dan Sampel Kotamobagu C 83.163 ± 6.354.Daun Gedi dari kota Bitung, Manado dan Kotamobagu ini memiliki spektrum yang relatif sama. Kombinasi ini melibatkan dari spektrum FTIR sebagai variabelx dan data hasil analisis metode DPPH sebagai variabely. Model prediksi dapat digunakan karena memiliki nilai kesalahan (standar error calibration (SEC = 0.0615), standard error of prediction (SEP = 0.0763)) dan nilai r kalibrasi 0.4181, serta r validasi 0.2917. Kata Kunci : Antioksidan, Daun Gedi Hijau, Spektrofotometri FTIR, Spektrofotometri UV-VIS, Kemometrik.
- Published
- 2017
21. Is remote live urologic surgery a reality? Evidences from a systematic review of the literature.
- Author
-
Veneziano, Domenico, Tafuri, A., Rivas, J. Gomez, Dourado, A., Okhunov, Z., Somani, B. K., Marino, N., Fuchs, G., and Cacciamani, G.
- Subjects
MINIMALLY invasive procedures ,META-analysis ,APPROPRIATE technology ,WEB databases ,UROLOGICAL surgery - Abstract
Introduction and objectives: The possibility of performing remote-surgery has been the goal to achieve, since the early development of the first surgical robotic platforms. This systematic review aims to analyse the state of the art in the field and to provide an overview of the possible growth of this technology. Methods: All English language publications on Telementoring and Telesurgery for minimally invasive urologic procedures were evaluated. We followed the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) statement to evaluate PubMed
® , Scopus® , and Web of Science™ databases (up to June 2019). Results: Our electronic search identified a total of 124 papers in PubMed, Scopus, and Web of Science. Of these, 81 publications were identified for detailed review, which yielded 22 included in the present systematic review. Our results showed that remote surgery has been under-utilised until today, mostly due to the lack of appropriate telecommunication technologies. Conclusion: Remote live surgery is a growing technology that is catalyzing incremental interest. Despite not being yet reliable today on a regular basis in its most advanced applications, thanks to the advent of novel data-transmission technologies, telepresence might become a critical educational methodology, highly impacting the global healthcare system [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
22. P149 Median arcuate ligament syndrome (Mals-Dunbar syndrome) in prepubertal patient: case report
- Author
-
Illiceto, M.T., primary, Lisi, G., additional, Filippone, M., additional, Marino, N., additional, Di Pietro, M., additional, Lombardi, G., additional, and Lelli Chiesa, P., additional
- Published
- 2018
- Full Text
- View/download PDF
23. Severe Bone Marrow Suppression Associated with Use of Clopidogrel
- Author
-
Spaccavento C, Zacharia G, Randhawa A, and Marino N
- Subjects
0301 basic medicine ,medicine.medical_specialty ,business.industry ,030204 cardiovascular system & hematology ,Clopidogrel ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Bone marrow suppression ,Adverse drug event ,Open access publishing ,Internal medicine ,Medicine ,business ,medicine.drug - Published
- 2016
24. Pluronic (R) P123/F127 mixed micelles delivering sorafenib and its combination with verteporfin in cancer cells
- Author
-
Pellosi, D. S., Moret, F., Fraix, A., Marino, N., Maiolino, S., Gaio, E., Hioka, N., Reddi, E., Sortino, Salvatore, and Quaglia, F.
- Published
- 2016
25. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
- Author
-
Postorino, M. C, Prosperi, M., QUIROS ROLDAN, Maria Eugenia, Maggiolo, F., Di Giambenedetto, S., Saracino, A., Costarelli, S., Lorenzotti, S., Sighinolfi, L., Di Pietro, M., Torti, Carlo, Castelli, Francesco, Carosi, Giampiero, Nasta, Paola, Paraninfo, G., Foca', Emanuele, Torti, C., Cauda, R., Fabbiani, M., Colafigli, M., Scalzini, Alfredo, Castelnuovo, F., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Ladisa, N., Monno, L., Maggi, Paolo, Pan, A., Gori, A., Lapadula, G., Ospedale, S., Puoti, M., Viale, P., Colangeli, V., Borderi, M., Policlinico, S., Postorino, M. C., Prosperi, M., Quiros-Roldan, E., Maggiolo, F., Di Giambenedetto, S., Saracino, A., Costarelli, S., Lorenzotti, S., Sighinolfi, L., Di Pietro, M., Torti, C., Castelli, F., Carosi, G., Nasta, P., Paraninfo, G., Foca, E., Cauda, R., Fabbiani, M., Colafigli, M., Scalzini, A., Castelnuovo, F., Mazzotta, F., Locaputo, S., Marino, N., Pierotti, P., Ble, C., Vichi, F., Angarano, G., Ladisa, N., Monno, L., Maggi, P., Pan, A., Gori, A., Lapadula, G., Ospedale, S., Puoti, M., Viale, P., Colangeli, V., Borderi, M., and Policlinico, S.
- Subjects
Cyclopropanes ,Male ,AIDS event ,HIV Infections ,Cohort Studies ,chemistry.chemical_compound ,Antiretroviral Therapy, Highly Active ,HIV Infection ,Viral ,immunological response ,ritonavir-boosted protease inhibitors ,composite outcome ,virus diseases ,Lopinavir ,General Medicine ,Hepatitis C ,Middle Aged ,Viral Load ,non-nucleoside reverse transcriptase inhibitors ,Death ,Ritonavir-boosted protease inhibitor ,Treatment Outcome ,Infectious Diseases ,Anti-Retroviral Agents ,Italy ,Alkynes ,Cohort ,RNA, Viral ,Female ,Viral load ,Human ,medicine.drug ,Cohort study ,Benzoxazine ,Adult ,Microbiology (medical) ,medicine.medical_specialty ,Efavirenz ,Atazanavir Sulfate ,virological response ,Antiretroviral Therapy ,Non-nucleoside reverse transcriptase inhibitor ,AIDS events ,Composite outcome ,Deaths ,First-line therapy ,Immunological response ,Non-nucleoside reverse transcriptase inhibitors ,Ritonavir-boosted protease inhibitors ,Virological response ,Benzoxazines ,CD4 Lymphocyte Count ,Humans ,Ritonavir ,Settore MED/17 - MALATTIE INFETTIVE ,first-line therapy ,Internal medicine ,medicine ,Highly Active ,business.industry ,Odds ratio ,medicine.disease ,deaths ,chemistry ,Immunology ,RNA ,Anti-Retroviral Agent ,Cohort Studie ,business - Abstract
Randomized trials and observational cohorts reported higher rates of virological suppression after highly active antiretroviral therapy (HAART) including efavirenz (EFV), compared with boosted protease inhibitors (PIs). Correlations with immunological and clinical outcomes are unclear. Patients of the Italian MASTER cohort who started HAART from 2000 to 2010 were selected. Outstanding outcome (composite outcome for success (COS)) was introduced. We evaluated predictors of COS (no AIDS plus CD4+ count >500/mm3 plus HIV-RNA
- Published
- 2015
26. Endoscopic-assisted Heller extramucosal myotomy with antireflux anterior fundoplication (DOR) in robotic approach for esophageal achalasia (EA)
- Author
-
Illiceto, M.T., primary, Lisi, G., additional, Filippone, M., additional, Marino, N., additional, Chiesa, P. Lelli, additional, and Lombardi, G., additional
- Published
- 2016
- Full Text
- View/download PDF
27. Unexpected Left Atrial Reinfusion through a Patent Foramen Ovale during Venovenous Extracorporeal Life Support
- Author
-
Marino, N. Bottino A., primary, Polli, F., additional, Savioli, M., additional, Tubiolo, D., additional, Iapichino, G. E., additional, Protti, A., additional, and Gattinoni, L., additional
- Published
- 2016
- Full Text
- View/download PDF
28. The INSIDE Project: Innovative Solutions for In-Beam Dosimetry in Hadrontherapy
- Author
-
Marafini, M., primary, Attili, A., additional, Battistoni, G., additional, Belcari, N., additional, Bisogni, M.G., additional, Camarlinghi, N., additional, Cappucci, F., additional, Cecchetti, M., additional, Cerello, P., additional, Ciciriello, F., additional, Cirrone, G.A.P., additional, Coli, S., additional, Corsi, F., additional, Cuttone, G., additional, De Lucia, E., additional, Ferretti, S., additional, Faccini, R., additional, Fiorina, E., additional, Frallicciardi, P.M., additional, Giraudo, G., additional, Kostara, E., additional, Kraan, A., additional, Licciulli, F., additional, Liu, B., additional, Marino, N., additional, Marzocca, C., additional, Matarrese, G., additional, Morone, C., additional, Morrocchi, M., additional, Muraro, S., additional, Patera, V., additional, Pennazio, F., additional, Peroni, C., additional, Piersanti, L., additional, Piliero, M.A., additional, Pirrone, G., additional, Rivetti, A., additional, Romano, F., additional, Rosso, V., additional, Sala, P., additional, Sarti, A., additional, Sciubba, A., additional, Sportelli, G., additional, Voena, C., additional, Wheadon, R., additional, and Del Guerra, A., additional
- Published
- 2015
- Full Text
- View/download PDF
29. A Study of Monitoring Performances with the INSIDE System
- Author
-
Pennazio, F., primary, Attili, A., additional, Battistoni, G., additional, Belcari, N., additional, Bisogni, M.G., additional, Camarlinghi, N., additional, Cappucci, F., additional, Cecchetti, M., additional, Cerello, P., additional, Ciciriello, F., additional, Cirrone, G.A.P., additional, Coli, S., additional, Corsi, F., additional, Cuttone, G., additional, De Lucia, E., additional, Ferretti, S., additional, Faccini, R., additional, Fiorina, E., additional, Frallicciardi, P.M., additional, Giraudo, G., additional, Kostara, E., additional, Kraan, A., additional, Licciulli, F., additional, Liu, B., additional, Marafini, M., additional, Marino, N., additional, Marzocca, C., additional, Matarrese, G., additional, Morone, C., additional, Morrocchi, M., additional, Muraro, S., additional, Patera, V., additional, Peroni, C., additional, Piersanti, L., additional, Piliero, M.A., additional, Pirrone, G., additional, Rivetti, A., additional, Romano, F., additional, Rosso, V., additional, Sala, P., additional, Sarti, A., additional, Sciubba, A., additional, Sportelli, G., additional, Voena, C., additional, Wheadon, R., additional, and Del Guerra, A., additional
- Published
- 2015
- Full Text
- View/download PDF
30. Effectiveness of tai chi on balance improvement in type 2 diabetes patients: A systematic review and meta-analysis
- Author
-
Felice Sirico, Carlo Loiacono, Stefano Palermi, Nastasia Marino, Francesco Gambardella, Anna Maria Sacco, Immacolata Belviso, Palermi, S., Sacco, A. M., Belviso, I., Marino, N., Gambardella, F., Loiacono, C., and Sirico, F.
- Subjects
medicine.medical_specialty ,education ,MEDLINE ,Psychological intervention ,Physical Therapy, Sports Therapy and Rehabilitation ,Type 2 diabetes ,CINAHL ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Diabetes mellitus ,medicine ,Fall ,030212 general & internal medicine ,Exercise ,business.industry ,Prevention ,Rehabilitation ,medicine.disease ,Confidence interval ,Meta-analysis ,Coordination ,Hyperglycemia ,Physical therapy ,Geriatrics and Gerontology ,business ,Gerontology ,030217 neurology & neurosurgery - Abstract
Balance impairments are a relevant problem in patients with diabetes, and interventions to manage this issue represent a public health need. This study reviewed the literature about the effectiveness of Tai Chi on balance improvement in patients with type 2 diabetes. Springerlink, MEDLINE, PubMed, CINAHL, Web of Science, Scopus, and Cochrane CENTRAL databases were screened. Randomized and nonrandomized controlled trials assessing balance in patients with type 2 diabetes enrolled in a Tai Chi program were considered eligible. Four studies were included in qualitative synthesis and in quantitative analysis (three randomized controlled trials and one pretest–posttest quasi-experimental study). Evidence supporting Tai Chi to improve balance in patients with type 2 diabetes was found (effect size: 0.52; 95% confidence interval [0.20, 0.84]); however, the analysis relied on a small number of studies, which raises concerns about the risk of bias. In conclusion, the results support the benefits of Tai Chi intervention to improve balance in patients with type 2 diabetes.
- Published
- 2020
31. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
- Author
-
Monica Lupi, Daniela Silvestri, Giovanna D'Amico, Maria Grazia Valsecchi, Geertruy te Kronnie, Barbara Russo, Fabio Pagni, Franco Locatelli, Patrizia Vergani, Carmelo Rizzari, Andrea Biondi, Noemi Marino, Federica Portale, Giulia Cricrì, Stefania Gaspari, Silvia Bresolin, Paolo Ubezio, Erica Dander, Portale, F, Cricrì, G, Bresolin, S, Lupi, M, Gaspari, S, Silvestri, D, Russo, B, Marino, N, Ubezio, P, Pagni, F, Vergani, P, Te Kronnie, G, Valsecchi, M, Locatelli, F, Rizzari, C, Biondi, A, Dander, E, and D'Amico, G
- Subjects
Stromal cell ,CD34 ,Bone Marrow Cells ,Biology ,Article ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Bone Marrow ,Cell Movement ,Cell Line, Tumor ,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma ,Biomarkers, Tumor ,medicine ,Animals ,Humans ,Pediatric Acute Lymphoblastic Leukemia ,B cell ,Cell Proliferation ,Gene Expression Regulation, Leukemic ,Mesenchymal stem cell ,activinA ,precursor B-cell ,acute lymphoblastic leukemia ,Mesenchymal Stem Cells ,Hematology ,Acute Lymphoblastic Leukemia ,medicine.disease ,Activins ,Bone Marrow Microenvironment ,Disease Models, Animal ,Haematopoiesis ,Leukemia ,Mesenchymal Stem Cell ,medicine.anatomical_structure ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,Cell culture ,Cancer research ,Cytokines ,Bone marrow ,Inflammation Mediators ,Stromal Cells ,ALL ,030215 immunology - Abstract
B-cell precursor-acute lymphoblastic leukemia modulates the bone marrow (BM) niche to become leukemia-supporting and chemo-protective by reprogramming the stromal microenvironment. New therapies targeting the interplay between leukemia and stroma can help improve disease outcome. We identified ActivinA, a TGF-b family member with a well-described role in promoting several solid malignancies, as a factor favoring leukemia that could represent a new potential target for therapy. ActivinA resulted over-expressed in the leukemic BM and its production was strongly induced in mesenchymal stromal cells after culture with leukemic cells. Moreover, MSCs isolated from BM of leukemic patients showed an intrinsic ability to secrete higher amounts of ActivinA compared to their normal counterparts. The pro-inflammatory leukemic BM microenvironment synergized with leukemic cells to induce stromal-derived ActivinA. Gene expression analysis of ActivinA-treated leukemic cells showed that this protein was able to significantly influence motility-associated pathways. Interestingly, ActivinA promoted random motility and CXCL12-driven migration of leukemic cells, even at suboptimal chemokine concentrations, characterizing the leukemic niche. Conversely, ActivinA severely impaired CXCL12-induced migration of healthy CD34 + cells. This opposite effect can be explained by the ability of ActivinA to increase intracellular calcium only in leukemic cells, boosting cytoskeleton dynamics through a higher rate of actin polymerization. Moreover, by stimulating the invasiveness of the leukemic cells, ActivinA was found to be a leukemia-promoting factor. Importantly, the ability of ActivinA to enhance BM engraftment and the metastatic potential of leukemic cells was confirmed in a xenograft mouse model of the disease. Overall, ActivinA was seen to be a key factor in conferring a migratory advantage to leukemic cells over healthy hematopoiesis within the leukemic niche.
- Published
- 2018
32. Hierarchical organization of perylene bisimides and polyoxometalates for photo-assisted water oxidation
- Author
-
Nicola Demitri, Nadia Marino, Erica Pizzolato, Konstantin Dirian, Giuseppina La Ganga, Zois Syrgiannis, Carlo Alberto Bignozzi, Marcella Bonchio, Dirk M. Guldi, Stefano Caramori, Maurizio Prato, Francesco Rigodanza, Giulia Alice Volpato, Heinz Amenitsch, Andrea Sartorel, Serena Berardi, Max Burian, Bonchio, M., Syrgiannis, Z., Burian, M., Marino, N., Pizzolato, E., Dirian, K., Rigodanza, F., Volpato, G. A., La Ganga, G., Demitri, N., Berardi, S., Amenitsch, H., Guldi, D. M., Caramori, S., Bignozzi, C. A., Sartorel, A., and Prato, M.
- Subjects
Photosystem II ,General Chemical Engineering ,chemistry.chemical_element ,CATALYSTS ,010402 general chemistry ,Photochemistry ,01 natural sciences ,7. Clean energy ,Catalysis ,Artificial photosynthesis ,chemistry.chemical_compound ,Nanoscience and technology ,WO3 ,polyoxometalate ,polyoxometalates ,Chemical Engineering (all) ,perylene bisimides ,photo-assisted water oxidation ,Photocatalysis ,perylene bisimide ,Chemistry ,Nanoscale materials ,010405 organic chemistry ,PHOTODRIVEN ELECTRON-TRANSPORT ,Chemistry (all) ,Oxygen evolution ,Ambientale ,General Chemistry ,ARTIFICIAL PHOTOSYNTHESIS ,0104 chemical sciences ,Ruthenium ,chemistry ,HEXAGONAL HII PHASE ,Polyoxometalate ,Quantasome ,PHOTODRIVEN ELECTRON-TRANSPORT, HEXAGONAL HII PHASE, ARTIFICIAL PHOTOSYNTHESIS, BIVO4 PHOTOANODES, CHARGE SEPARATION, CATALYSTS, WO3 ,Perylene ,BIVO4 PHOTOANODES ,CHARGE SEPARATION - Abstract
The oxygen in Earth’s atmosphere is there primarily because of water oxidation performed by photosynthetic organisms using solar light and one specialized protein complex, photosystem II (PSII). High-resolution imaging of the PSII ‘core’ complex shows the ideal co-localization of multi-chromophore light-harvesting antennas with the functional reaction centre. Man-made systems are still far from replicating the complexity of PSII, as the majority of PSII mimetics have been limited to photocatalytic dyads based on a 1:1 ratio of a light absorber, generally a Ru–polypyridine complex, with a water oxidation catalyst. Here we report the self-assembly of multi-perylene-bisimide chromophores (PBI) shaped to function by interaction with a polyoxometalate water-oxidation catalyst (Ru4POM). The resulting [PBI]5Ru4POM complex shows a robust amphiphilic structure and dynamic aggregation into large two-dimensional paracrystalline domains, a redshifted light-harvesting efficiency of >40% and favourable exciton accumulation, with a peak quantum efficiency using ‘green’ photons (λ > 500 nm). The modularity of the building blocks and the simplicity of the non-covalent chemistry offer opportunities for innovation in artificial photosynthesis. In native photosystem II (PSII), multi-chromophore antennas surround the reaction centre, capturing light and triggering the quantized (four-flashes) photo-oxidation of water to oxygen. The PSII ‘quantasome’ is the most efficient photo-electrolyser built so far. An artificial quantasome has now been developed; it is specifically designed for oxygen evolution by self-assembling light-harvesting-perylene bisimides with a ruthenium polyoxometalate water-oxidation catalyst.
- Published
- 2019
33. A functional connectome: regulation of Wnt/TCF-dependent transcription by pairs of pathway activators
- Author
-
Freeman, Jamie, Smith, David, Latinkic, Branko, Ewan, Ken, Samuel, Lee, Zollo, Massimo, Marino, Natascia, Tyas, Lorraine, Jones, Nick, Dale, Trevor C., Freeman, J, Smith, D, Latinkic, B, Ewan, K, Samuel, L, Zollo, Massimo, Marino, N, Tyas, L, Jones, N, and Dale, T. c.
- Subjects
Cancer Research ,Transcription, Genetic ,Drug discovery ,Research ,Protein complexes ,Network ,Antineoplastic Agents ,Wnt signaling ,Gene Expression Regulation, Neoplastic ,Wnt Proteins ,RC0254 ,Xenopus laevis ,HEK293 Cells ,Oncology ,Protein complexe ,Cell Line, Tumor ,Animals ,Humans ,Molecular Medicine ,Gene Regulatory Networks ,Protein Interaction Maps ,TCF Transcription Factors ,Wnt Signaling Pathway ,Cancer - Abstract
Background Wnt/β-catenin signaling is often portrayed as a simple pathway that is initiated by Wnt ligand at the cell surface leading, via linear series of interactions between ‘core pathway’ members, to the induction of nuclear transcription from genes flanked by β-catenin/TCF transcription factor binding sites. Wnt/β-catenin signaling is also regulated by a much larger set of ‘non-core regulators’. However the relationship between ‘non-core regulators’ is currently not well understood. Aberrant activation of the pathway has been shown to drive tumorgenesis in a number of different tissues. Methods Mammalian cells engineered to have a partially-active level of Wnt/β-catenin signaling were screened by transfection for proteins that up or down-regulated a mid-level of TCF-dependent transcription induced by transient expression of an activated LRP6 Wnt co-receptor (∆NLRP). Results 141 novel regulators of TCF-dependent transcription were identified. Surprisingly, when tested without ∆NLRP activation, most up-regulators failed to alter TCF-dependent transcription. However, when expressed in pairs, 27 % (466/1170) functionally interacted to alter levels of TCF-dependent transcription. When proteins were displayed as nodes connected by their ability to co-operate in the regulation of TCF-dependent transcription, a network of functional interactions was revealed. In this network, ‘core pathway’ components (Eg. β-catenin, GSK-3, Dsh) were found to be the most highly connected nodes. Activation of different nodes in this network impacted on the sensitivity to Wnt pathway small molecule antagonists. Conclusions The ‘functional connectome’ identified here strongly supports an alternative model of the Wnt pathway as a complex context-dependent network. The network further suggests that mutational activation of highly connected Wnt signaling nodes predisposed cells to further context-dependent alterations in levels of TCF-dependent transcription that may be important during tumor progression and treatment. Electronic supplementary material The online version of this article (doi:10.1186/s12943-015-0475-1) contains supplementary material, which is available to authorized users.
- Published
- 2015
34. Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn 2+ , Cu 2+ , Zn 2+ , Ga 3+ , In 3+ , Tb 3+ , and Lu 3 .
- Author
-
Hierlmeier I, Marino N, Schreck MV, Schneider L, Maus S, Barrett K, Kretowicz M, Engle JW, Pierri G, Ezziddin S, and Bartholomä MD
- Abstract
In this work, we describe the complex formation and radiochemistry of the cyclen-based chelator DOTI-Me bearing four methylimidazole arms. Radiolabeling properties were evaluated for
52g Mn,64 Cu,68 Ga,111 In,161 Tb, and177 Lu, and DOTI-Me showed distinct differences to the structurally related H4 DOTA. While radiochemical conversions (RCCs) for52g Mn and111 In were comparable to those of H4 DOTA, DOTI-Me was not suited for68 Ga. Conversely, quantitative RCCs were achieved for64 Cu at ambient temperature, while elevated temperatures were required for complexation with H4 DOTA. For161 Tb and177 Lu, good but not quantitative RCCs were obtained with DOTI-Me. With the exemption of68 Ga3+ , radiolabeled complexes showed high stability in ligand challenge experiments and in human serum. X-ray analysis of the nonradioactive complexes revealed the formation of 8-coordinate Mn2+ and In3+ DOTI-Me complexes. Cu2+ adopted a unique distorted square-pyramidal 2 + 3 with the neutral DOTI-Me ligand and a Jahn-Teller distorted 4 + 2 coordination geometry for the diprotonated H2 DOTI-Me2+ cation, respectively. For Zn2+ , the complex with HDOTI-Me+ showed a distorted 4 + 3 pentagonal bipyramidal geometry. Summarizing, the ligand DOTI-Me may be an interesting alternative to H4 DOTA for52g Mn,64 Cu,111 In,161 Tb, and177 Lu, covering diagnostic as well as therapeutic radionuclides. Further studies of targeted radiopharmaceuticals based on the DOTI-Me scaffold in combination with the set of radiometals presented herein are thus warranted.- Published
- 2024
- Full Text
- View/download PDF
35. Dietary fiber promotes antigen presentation on intestinal epithelial cells and development of small intestinal CD4 + CD8αα + intraepithelial T cells.
- Author
-
Rodriguez-Marino N, Royer CJ, Rivera-Rodriguez DE, Seto E, Gracien I, Jones RM, Scharer CD, Gracz AD, and Cervantes-Barragan L
- Abstract
The impact of dietary fiber on intestinal T cell development is poorly understood. Here we show that a low fiber diet reduces MHC-II antigen presentation by small intestinal epithelial cells (IECs) and consequently impairs development of CD4
+ CD8αα+ intraepithelial lymphocytes (DP IELs) through changes to the microbiota. Dietary fiber supports colonization by Segmented Filamentous Bacteria (SFB), which induces the secretion of IFNγ by type 1 innate lymphoid cells (ILC1s) that lead to MHC-II upregulation on IECs. IEC MHC-II expression caused either by SFB colonization or exogenous IFNγ administration induced differentiation of DP IELs. Finally, we show that a low fiber diet promotes overgrowth of Bifidobacterium pseudolongum, and that oral administration of B. pseudolongum reduces SFB abundance in the small intestine. Collectively we highlight the importance of dietary fiber in maintaining the balance among microbiota members that allow IEC MHC-II antigen presentation and define a mechanism of microbiota-ILC-IEC interactions participating in the development of intestinal intraepithelial T cells., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
36. A Very Early Diagnosis of Complete Androgen Insensitivity Syndrome Due to a Novel Variant in the AR Gene: A Neonatal Case Study.
- Author
-
Ferrante R, Tumini S, Saltarelli MA, Di Rado S, Scorrano V, Tommolini ML, Zucchelli M, Lauriola F, Lisi G, Lauriti G, Marino N, Stuppia L, Rossi C, and Bucci I
- Abstract
Androgen insensitivity syndrome (AIS) is one of the most common Disorders of Sexual Differentiation (DSDs). AIS is characterized by an X-linked recessive inheritance pattern associated with variants in the androgen receptor (AR) gene that affects the masculinization process in individuals with XY karyotype. Here, we report a neonatal case of a very early diagnosis of complete AIS due to a novel variant in the AR gene. In the present case, after the clinical evaluation, the infant has undergone the following tests: biochemical analyses, including newborn screening workflow, karyotype analysis, and Next-Generation Sequencing (NGS) panel of 50 genes involved in DSDs. The NGS analysis identified a missense variant, c.2108C>A, in the AR gene. According to a cytogenetic analysis, the patient presented a 46, XY karyotype, thus the resulting hemizygote for the AR gene variant. The variant is not currently described in the literature nor in the ClinVar database. However, according to computational models, the variant could have a pathogenetic effect. This clinical case reveals a novel variant of the AR gene with a possible pathogenetic effect associated with AIS and highlights the importance of a multidisciplinary approach for the timely diagnosis and appropriate follow-up of the patient.
- Published
- 2024
- Full Text
- View/download PDF
37. Magnetocaloric efficiency tuning through solvent-triggered 3D to 2D interconversion in holmium(III)-based dynamic MOFs.
- Author
-
El Alouani Dahmouni N, Orts-Arroyo M, Sanchis-Perucho A, Moliner N, Mayans J, Pacheco M, Castro I, De Munno G, Marino N, Ruiz-García R, and Martínez-Lillo J
- Abstract
The neutral holmium(III) oxalate octadecahydrate {[Ho
2 (ox)3 (H2 O)6 ]·12H2 O}n of mixed hexagonal/decagonal (63 ·103 ) 3D net topology shows important changes in the magnetocaloric efficiency upon dehydration/rehydration by heating and water vapor exposition to give the holmium(III) oxalate decahydrate {[Ho2 (ox)3 (H2 O)6 ]·4H2 O}n of hexagonal (63 ) 2D net topology through the intermediacy of the elusive amorphous anhydrous compound {Ho2 (ox)3 }n .- Published
- 2024
- Full Text
- View/download PDF
38. Author Correction: Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis.
- Author
-
Marino N, German R, Rao X, Simpson E, Liu S, Wan J, Liu Y, Sandusky G, Jacobsen M, Stovall M, Cao S, and Storniolo AMV
- Published
- 2024
- Full Text
- View/download PDF
39. Glitches in the brain: the dangerous relationship between radiotherapy and brain fog.
- Author
-
Marino N, Bedeschi M, Vaccari ME, Cambiaghi M, and Tesei A
- Abstract
Up to approximately 70% of cancer survivors report persistent deficits in memory, attention, speed of information processing, multi-tasking, and mental health functioning, a series of symptoms known as "brain fog." The severity and duration of such effects can vary depending on age, cancer type, and treatment regimens. In particular, every year, hundreds of thousands of patients worldwide undergo radiotherapy (RT) for primary brain tumors and brain metastases originating from extracranial tumors. Besides its potential benefits in the control of tumor progression, recent studies indicate that RT reprograms the brain tumor microenvironment inducing increased activation of microglia and astrocytes and a consequent general condition of neuroinflammation that in case it becomes chronic could lead to a cognitive decline. Furthermore, radiation can induce endothelium reticulum (ER) stress directly or indirectly by generating reactive oxygen species (ROS) activating compensatory survival signaling pathways in the RT-surviving fraction of healthy neuronal and glial cells. In particular, the anomalous accumulation of misfolding proteins in neuronal cells exposed to radiation as a consequence of excessive activation of unfolded protein response (UPR) could pave the way to neurodegenerative disorders. Moreover, exposure of cells to ionizing radiation was also shown to affect the normal proteasome activity, slowing the degradation rate of misfolded proteins, and further exacerbating ER-stress conditions. This compromises several neuronal functions, with neuronal accumulation of ubiquitinated proteins with a consequent switch from proteasome to immunoproteasome that increases neuroinflammation, a crucial risk factor for neurodegeneration. The etiology of brain fog remains elusive and can arise not only during treatment but can also persist for an extended period after the end of RT. In this review, we will focus on the molecular pathways triggered by radiation therapy affecting cognitive functions and potentially at the origin of so-called "brain fog" symptomatology, with the aim to define novel therapeutic strategies to preserve healthy brain tissue from cognitive decline., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Marino, Bedeschi, Vaccari, Cambiaghi and Tesei.)
- Published
- 2024
- Full Text
- View/download PDF
40. Biofilm-derived oxylipin 10-HOME-mediated immune response in women with breast implants.
- Author
-
Khan I, Minto RE, Kelley-Patteson C, Singh K, Timsina L, Suh LJ, Rinne E, Van Natta BW, Neumann CR, Mohan G, Lester M, VonDerHaar RJ, German R, Marino N, Hassanein AH, Gordillo GM, Kaplan MH, Sen CK, Kadin ME, and Sinha M
- Subjects
- Humans, Female, Mice, Animals, Oxylipins, Biofilms, Immunity, Breast Implants adverse effects, Breast Implants microbiology
- Abstract
This study investigates a mechanistic link of bacterial biofilm-mediated host-pathogen interaction leading to immunological complications associated with breast implant illness (BII). Over 10 million women worldwide have breast implants. In recent years, women have described a constellation of immunological symptoms believed to be related to their breast implants. We report that periprosthetic breast tissue of participants with symptoms associated with BII had increased abundance of biofilm and biofilm-derived oxylipin 10-HOME compared with participants with implants who are without symptoms (non-BII) and participants without implants. S. epidermidis biofilm was observed to be higher in the BII group compared with the non-BII group and the normal tissue group. Oxylipin 10-HOME was found to be immunogenically capable of polarizing naive CD4+ T cells with a resulting Th1 subtype in vitro and in vivo. Consistently, an abundance of CD4+Th1 subtype was observed in the periprosthetic breast tissue and blood of people in the BII group. Mice injected with 10-HOME also had increased Th1 subtype in their blood, akin to patients with BII, and demonstrated fatigue-like symptoms. The identification of an oxylipin-mediated mechanism of immune activation induced by local bacterial biofilm provides insight into the possible pathogenesis of the implant-associated immune symptoms of BII.
- Published
- 2023
- Full Text
- View/download PDF
41. Low dietary fiber intake impairs small intestinal Th17 and intraepithelial T cell development over generations.
- Author
-
Royer CJ, Rodriguez-Marino N, Yaceczko MD, Rivera-Rodriguez DE, Ziegler TR, and Cervantes-Barragan L
- Subjects
- Mice, Animals, Intestine, Small microbiology, Receptors, Antigen, T-Cell, alpha-beta, Intestinal Mucosa microbiology, Dietary Fiber, Mice, Inbred C57BL, Intraepithelial Lymphocytes, Microbiota, Gastrointestinal Microbiome
- Abstract
Dietary fiber strongly impacts the microbiota. Here, we show that a low-fiber diet changes the small intestinal (SI) microbiota and impairs SI Th17, TCRαβ
+ CD8αβ+ and TCRαβ+ CD8αα+ intraepithelial T cell development. We restore T cell development with dietary fiber supplementation, but this defect becomes persistent over generations with constant low-fiber diets. Offspring of low-fiber diet-fed mice have reduced SI T cells even after receiving a fiber-rich diet due to loss of bacteria important for T cell development. In these mice, only a microbiota transplant from a fiber-rich diet-fed mouse and a fiber-rich diet can restore T cell development. Low-fiber diets reduce segmented filamentous bacteria (SFB) abundance, impairing its vertical transmission. SFB colonization and a fiber-rich diet partially restore T cell development. Finally, we observe that low-fiber diet-induced T cell defects render mice more susceptible to Citrobacter rodentium infection. Together, these results demonstrate the importance of fiber to microbiota vertical transmission and host immune system development., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
42. LAT1 (SLC7A5) catalyzes copper(histidinate) transport switching from antiport to uniport mechanism.
- Author
-
Scanga R, Scalise M, Marino N, Parisi F, Barca D, Galluccio M, Brunocilla C, Console L, and Indiveri C
- Abstract
LAT1 (SLC7A5) is one of the most studied membrane transporters due to its relevance to physiology in supplying essential amino acids to brain and fetus, and to pathology being linked to nervous or embryo alterations; moreover, LAT1 over-expression is always associated with cancer development. Thus, LAT1 is exploited as a pro-drug vehicle and as a target for anti-cancer therapy. We here report the identification of a new substrate with pathophysiological implications, i.e., Cu-histidinate, and an unconventional uniport mechanism exploited for the Cu-histidinate transport. Crystals of the monomeric species Cu(His)
2 were obtained in our experimental conditions and the actual transport of the complex was evaluated by a combined strategy of bioinformatics, site-directed mutagenesis, radiolabeled transport, and mass spectrometry analysis. The LAT1-mediated transport of Cu(His)2 may have profound implications for both the treatment of copper dysmetabolism diseases, such as the rare Menkes disease, and of cancer as an alternative to platinum-based therapies., Competing Interests: The authors declare no competing interests., (© 2023 The Authors.)- Published
- 2023
- Full Text
- View/download PDF
43. Exploring breast tissue microbial composition and the association with breast cancer risk factors.
- Author
-
German R, Marino N, Hemmerich C, Podicheti R, Rusch DB, Stiemsma LT, Gao H, Xuei X, Rockey P, and Storniolo AM
- Subjects
- Pregnancy, Humans, Female, Dysbiosis, RNA, Ribosomal, 16S genetics, Lactobacillus genetics, Breast Neoplasms etiology, Breast Neoplasms genetics
- Abstract
Background: Microbial dysbiosis has emerged as an important element in the development and progression of various cancers, including breast cancer. However, the microbial composition of the breast from healthy individuals, even relative to risk of developing breast cancer, remains unclear. Here, we performed a comprehensive analysis of the microbiota of the normal breast tissue, which was analyzed in relation to the microbial composition of the tumor and adjacent normal tissue., Methods: The study cohorts included 403 cancer-free women (who donated normal breast tissue cores) and 76 breast cancer patients (who donated tumor and/or adjacent normal tissue samples). Microbiome profiling was obtained by sequencing the nine hypervariable regions of the 16S rRNA gene (V1V2, V2V3, V3V4, V4V5, V5V7, and V7V9). Transcriptome analysis was also performed on 190 normal breast tissue samples. Breast cancer risk score was assessed using the Tyrer-Cuzick risk model., Results: The V1V2 amplicon sequencing resulted more suitable for the analysis of the normal breast microbiome and identified Lactobacillaceae (Firmicutes phylum), Acetobacterraceae, and Xanthomonadaceae (both Proteobacteria phylum) as the most abundant families in the normal breast. However, Ralstonia (Proteobacteria phylum) was more abundant in both breast tumors and histologically normal tissues adjacent to malignant tumors. We also conducted a correlation analysis between the microbiome and known breast cancer risk factors. Abundances of the bacterial taxa Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp. were associated with age (p < 0.0001), racial background (p < 0.0001), and parity (p < 0.0001). Finally, transcriptome analysis of normal breast tissues showed an enrichment in metabolism- and immune-related genes in the tissues with abundant Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp., whereas the presence of Ralstonia in the normal tissue was linked to dysregulation of genes involved in the carbohydrate metabolic pathway., Conclusions: This study defines the microbial features of normal breast tissue, thus providing a basis to understand cancer-related dysbiosis. Moreover, the findings reveal that lifestyle factors can significantly affect the normal breast microbial composition., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
44. Discovery of RC-752, a Novel Sigma-1 Receptor Antagonist with Antinociceptive Activity: A Promising Tool for Fighting Neuropathic Pain.
- Author
-
Rossino G, Marra A, Listro R, Peviani M, Poggio E, Curti D, Pellavio G, Laforenza U, Dondio G, Schepmann D, Wünsch B, Bedeschi M, Marino N, Tesei A, Ha HJ, Kim YH, Ann J, Lee J, Linciano P, Di Giacomo M, Rossi D, and Collina S
- Abstract
Neuropathic pain (NP) is a chronic condition resulting from damaged pain-signaling pathways. It is a debilitating disorder that affects up to 10% of the world's population. Although opioid analgesics are effective in reducing pain, they present severe risks; so, there is a pressing need for non-opioid pain-relieving drugs. One potential alternative is represented by sigma-1 receptor (S1R) antagonists due to their promising analgesic effects. Here, we report the synthesis and biological evaluation of a series of S1R antagonists based on a 2-aryl-4-aminobutanol scaffold. After assessing affinity toward the S1R and selectivity over the sigma-2 receptor (S2R), we evaluated the agonist/antagonist profile of the compounds by investigating their effects on nerve growth factor-induced neurite outgrowth and aquaporin-mediated water permeability in the presence and absence of oxidative stress. ( R / S )- RC - 752 emerged as the most interesting compound for S1R affinity ( K
i S1R = 6.2 ± 0.9) and functional antagonist activity. Furthermore, it showed no cytotoxic effect in two normal human cell lines or in an in vivo zebrafish model and was stable after incubation in mouse plasma. ( R / S )- RC - 752 was then evaluated in two animal models of NP: the formalin test and the spinal nerve ligation model. The results clearly demonstrated that compound ( R / S )- RC - 752 effectively alleviated pain in both animal models, thus providing the proof of concept of its efficacy as an antinociceptive agent.- Published
- 2023
- Full Text
- View/download PDF
45. Editorial: Sex steroid hormones: effects on breast cancer risk and etiology.
- Author
-
Mousa NA, Marino N, and Simões BM
- Subjects
- Humans, Female, Gonadal Steroid Hormones, Risk, Breast Neoplasms epidemiology, Breast Neoplasms etiology
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
46. Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents.
- Author
-
Linciano P, Sorbi C, Rossino G, Rossi D, Marsala A, Denora N, Bedeschi M, Marino N, Miserocchi G, Dondio G, Peviani M, Tesei A, Collina S, and Franchini S
- Subjects
- Animals, Humans, N-Methylaspartate pharmacology, N-Methylaspartate metabolism, Zebrafish metabolism, Oxidative Stress, Piperidines therapeutic use, Neuroprotective Agents pharmacology, Neuroprotective Agents therapeutic use, Neuroblastoma drug therapy, Neurodegenerative Diseases drug therapy, Receptors, sigma
- Abstract
Sigma-1 receptor (S1R) has been considered a promising therapeutic target for several neurodegenerative diseases and S1R agonists have shown neuroprotective activity against glutamate excitotoxicity and oxidative stress. Starting from a previously identified low nanomolar S1R agonist, in this work we prepared and tested novel benzylpiperidine/benzylpiperazine-based compounds designed by applying a ring opening strategy. Among them, 4-benzyl-1-(2-phenoxyethyl)piperidine 6b (S1R Ki = 0.93 nM) and 4-benzyl-1-(3-phenoxypropyl)piperidine 8b (S1R Ki = 1.1 nM) emerged as high affinity S1R ligands and showed selectivity over S2R and N-methyl-d-aspartate receptor (NMDAR). Candidate compounds behaved as potent S1R agonists being able to enhance the neurite outgrowth induced by nerve growth factor (NGF) in PC12 cell lines. In SH-SY5Y neuroblastoma cell lines they exhibited a neuroprotective effect against rotenone- and NMDA-mediated toxic insults. The neuroprotective activity of 6b and 8b was reverted by co-treatment with an S1R antagonist, PB212. Compounds 6b and 8b were tested for cytotoxicity in-vitro against three human cancer cell lines (A549, LoVo and Panc-1) and in-vivo zebrafish model, resulting in a good efficacy/safety profile, comparable or superior to the reference drug memantine. Overall, these results encourage further preclinical investigations of 6b and 8b on in-vivo models of neurodegenerative diseases., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
47. Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance.
- Author
-
Bedeschi M, Marino N, Cavassi E, Piccinini F, and Tesei A
- Subjects
- United States, Male, Humans, Androgen Antagonists therapeutic use, Drug Resistance, Neoplasm, Prostate pathology, Tumor Microenvironment, Prostatic Neoplasms pathology, Cancer-Associated Fibroblasts metabolism
- Abstract
Prostate cancer (PCa) is one of the most common cancers in European males. Although therapeutic approaches have changed in recent years, and several new drugs have been approved by the Food and Drug Administration (FDA), androgen deprivation therapy (ADT) remains the standard of care. Currently, PCa represents a clinical and economic burden due to the development of resistance to ADT, paving the way to cancer progression, metastasis, and to long-term side effects induced by ADT and radio-chemotherapeutic regimens. In light of this, a growing number of studies are focusing on the tumor microenvironment (TME) because of its role in supporting tumor growth. Cancer-associated fibroblasts (CAFs) have a central function in the TME because they communicate with prostate cancer cells, altering their metabolism and sensitivity to drugs; hence, targeted therapy against the TME, and, in particular, CAFs, could represent an alternative therapeutic approach to defeat therapy resistance in PCa. In this review, we focus on different CAF origins, subsets, and functions to highlight their potential in future therapeutic strategies for prostate cancer.
- Published
- 2023
- Full Text
- View/download PDF
48. Towards AI-driven longevity research: An overview.
- Author
-
Marino N, Putignano G, Cappilli S, Chersoni E, Santuccione A, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B, Mazzotta AD, and Santus E
- Abstract
While in the past technology has mostly been utilized to store information about the structural configuration of proteins and molecules for research and medical purposes, Artificial Intelligence is nowadays able to learn from the existing data how to predict and model properties and interactions, revealing important knowledge about complex biological processes, such as aging. Modern technologies, moreover, can rely on a broader set of information, including those derived from the next-generation sequencing (e.g., proteomics, lipidomics, and other omics), to understand the interactions between human body and the external environment. This is especially relevant as external factors have been shown to have a key role in aging. As the field of computational systems biology keeps improving and new biomarkers of aging are being developed, artificial intelligence promises to become a major ally of aging research., Competing Interests: Authors NM, GP, and AS, were employed by the company Women’s Brain Project (WBP). Authors EB, QV, and AZ were employed by the company Insilico Medicine Hong Kong Ltd. Author ES was employed by company Bayer Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Marino, Putignano, Cappilli, Chersoni, Santuccione, Calabrese, Bischof, Vanhaelen, Zhavoronkov, Scarano, Mazzotta and Santus.)
- Published
- 2023
- Full Text
- View/download PDF
49. Triacylglycerol Composition and Chemical-Physical Properties of Cocoa Butter and Its Derivatives: NMR, DSC, X-ray, Rheological Investigation.
- Author
-
Colella MF, Marino N, Oliviero Rossi C, Seta L, Caputo P, and De Luca G
- Subjects
- Humans, Triglycerides chemistry, X-Rays, Calorimetry, Differential Scanning, Fats, Magnetic Resonance Spectroscopy, Dietary Fats analysis, Fatty Acids chemistry
- Abstract
In recent years, the food industry has become increasingly involved in researching vegetable fats and oils with appropriate mechanical properties (ease of transport, processing, and storage) and a specific lipidic composition to ensure healthy products for consumers. The chemical-physical behavior of these matrices depends on their composition in terms of single fatty acids (FA). However, as we demonstrate in this work, these properties, as well as the absorption, digestion and uptake in humans of specific FAs, are also largely determined by their regiosomerism within the TriAcylGlycerols (TAG) moieties ( sn -1,2,3 positions). The goal of this work is to study for the first time vegetable fats obtained directly from a sample of natural cocoa butter (CB) through a process that manipulates the distribution of FAs but not their nature. Even if the initial percentage of each FA in the mixture remains the same, CB derivatives seem to show improved chemical-physical features. In order to understand which factors account for their physical and chemical characteristics, and to check whether or not the obtained new matrices could be considered as valid alternatives to other vegetable fats (e.g., palm oil (PO)), we carried out an experimental investigation at both the macroscopic and molecular level including: (i) Differential Scanning Calorimetry (DSC) analyses to examine thermal features; (ii) rheological testing to explore mechanical properties; (iii) powder X-ray diffraction (PXRD) to evaluate the solid-state phases of the obtained fats; and (iv)
1 H and13 C Nuclear Magnetic Resonance (NMR, 1D and 2D) spectroscopy to rapidly analyze fatty acid composition including regioisomeric distribution on the glycerol backbone. These last results open up the possibility of using NMR spectroscopy as an alternative to the chromatographic techniques routinely employed for the investigation of similar matrices.- Published
- 2023
- Full Text
- View/download PDF
50. Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women.
- Author
-
Sung H, Koka H, Marino N, Pfeiffer RM, Cora R, Figueroa JD, Sherman ME, Gierach GL, and Yang XR
- Subjects
- Breast, Female, Humans, Incidence, Risk, United States epidemiology, Breast Neoplasms epidemiology, Breast Neoplasms genetics, Mammary Glands, Human, Triple Negative Breast Neoplasms complications, Triple Negative Breast Neoplasms epidemiology, Triple Negative Breast Neoplasms genetics
- Abstract
Reduced age-related terminal duct lobular unit (TDLU) involution has been linked to increased breast cancer risk and triple-negative breast cancer. Associations of TDLU involution levels with race and ethnicity remain incompletely explored. Herein, we examined the association between genetic ancestry and TDLU involution in normal breast tissue donated by 2014 healthy women in the United States. Women of African ancestry were more likely than European women to have increased TDLU counts (odds ratio [OR]trend = 1.36, 95% confidence interval [CI] = 1.07 to 1.74), acini counts per TDLU (OR = 1.47, 95% CI = 1.06 to 2.03), and median TDLU span (ORtrend = 1.44, 95% CI = 1.08 to 1.91), indicating lower involution, whereas East Asian descendants were associated with decreased TDLU counts (ORtrend = 0.52, 95% CI = 0.35 to 0.78) after controlling for potential confounders. These associations are consistent with the racial variations in incidence rates of triple-negative breast cancer in the United States and suggest opportunities for future work examining whether TDLU involution may mediate the racial differences in subtype-specific breast cancer risk., (Published by Oxford University Press 2022. This work is written by US Government employees and is in the public domain in the US.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.